BlackRock Inc. - GALMED PHARMACEUTICALS LTD ownership

GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 24 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of GALMED PHARMACEUTICALS LTD
ValueSharesWeighting
Q1 2022$14,000
-17.6%
9,1160.0%0.00%
Q4 2021$17,000
-32.0%
9,1160.0%0.00%
Q3 2021$25,000
-10.7%
9,1160.0%0.00%
Q2 2021$28,000
-9.7%
9,1160.0%0.00%
Q1 2021$31,000
+29.2%
9,116
+19.7%
0.00%
Q4 2020$24,000
+14.3%
7,614
+29.6%
0.00%
Q3 2020$21,000
-25.0%
5,8770.0%0.00%
Q2 2020$28,000
-15.2%
5,877
+23.3%
0.00%
Q4 2018$33,0004,7650.00%
Other shareholders
GALMED PHARMACEUTICALS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 1,347,755$574,8180.02%
Virtu Financial LLC 31,633$130.00%
Western Wealth Management, LLC 29,537$12,5970.00%
Belpointe Asset Management LLC 14,050$5,9920.00%
TSFG, LLC 3,000$10.00%
ZRC WEALTH MANAGEMENT, LLC 100$430.00%
Allworth Financial LP 250$1070.00%
JANE STREET GROUP, LLC 13,189$5,6250.00%
RAYMOND JAMES & ASSOCIATES 138,040$58,8740.00%
BOURGEON CAPITAL MANAGEMENT LLC 500$2140.00%
View complete list of GALMED PHARMACEUTICALS LTD shareholders